We have meticulously designed and developed a pioneering class of compounds that set new standards in epilepsy treatment. These compounds boast unparalleled efficacy, a remarkable safety profile, and the potential to redefine patient compliance.

Game-Changing Results: Our flagship small molecule, the result of years of dedication and scientific rigor, has unveiled a groundbreaking breakthrough. In acute viable brain slices from multi drug-resistant human epilepsy patients, it has demonstrated exceptional anti-seizure efficacy and an extraordinary reduction in side effects compared to existing therapies, offering a glimmer of hope in epilepsy management like never before.